Perf Tech 3 Test 9 Flashcards

1
Q

Rotary VAD (2nd Gen VAD)

A
  • processes volume as it gets it, no pulsatile flow, no chambers to fill, axial flow design
  • rotating impellers to propel blod forward
  • supported with bearings
  • powered by spinning shaft/magnetic forces
  • problems= heat and bearings
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Rotary VAD Dates

A

1960- first described continuous flow pump
1998- DeBakey and Noon= axial flow LVAD
1999= Jarvik 2000
2000- Nimbus/HM2 axial flow pump

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Micromed

A

axial flow, smaller, easier, lower blood contact, less expensive/less parts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Heartmate II

A
  • electric, smaller, same system monitor/PBU as HMXVE
  • rotor spins with magnetic field on inlet and outlet of bearings (its the only movie part of pump)
  • uses RUBY bearings
  • flow is estimated! (by RPM and power consumption motor)- flow is not accurate below 3 l/min
  • VSA 1.15 to 3.15
  • implanted below L costal margin under rectus abdominus
  • still goes through diaphragm
  • issus- thrombus (can tell by increase power)- treat with TPA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

HMII History

A

-developed in early 1990s at U of Pittsburg

Nimbus to ThermoCardiosystmes (98) to Thoratec (2001) to St. Jude Medical (2016)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

REMATCH Trial

A

“randomized evolution of mechanical assistance for the treatment of congestive heart failure”
-Tested HMXVE vs. medical therapy alone
-1996
=found benefit at 1-2 year compared to medical therapy alone
-HMXVE approved for DT in 2002

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

HMII and Clinical Trials

A

HMII vs HMXVE
=end point was 2 years or adverse effect
-46% of HMII after 2 years had no adverse effects
-survival one year= 68%, two years= 58%
-HMII approved for BTT 2008 and DT in 2010

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Heartware HVAD

A
  • 3rd gen
  • rotary pump with centrifugal and non contact bearing design (magnet) - thin layer of blood
  • placed in pericardial cavity at apex= NO abdominal pocket
  • first implant 2006
  • Advance trial= approved for BTT in 2012
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

DuraHeart LVAS

A
  • rotary pump with Levitation system and impeller

- does have abdominal pocket

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Momentum 3 Trial

A

HMII vs HMIII for DT and BTT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Heartmate III

A
  • fully levitated magnetic impeller= no friction
  • pulsatile and textured surface= decrease clots
  • implanted above diaphragm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Percutaneous Devices

A

1) Abiomed Impella 2.5/5.0= intracatheter VAD
2) Thoratec Heartmate Percutaneous Heart Pump= similar to impella but inflates from 13 FR to 24 Fr (used for emergencies and NOT for CABG)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Misc VADs

A

3) Tandem Heart= takes blood from LA and gives it femoral artery!= transseptal cannula (flow is cannula dependent)
- floats in fluid bearing to cool and lubricate
- integraded air bubble detector, device self diagnose
4) Berlin Heart (Excor)= BTT 2011, compassionate use only, pneumatic device

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

two types of Angioplasty

A

1) percutaneous transluminal coronary angioplasty (PTCA)
- bloon that inflate
2) Stent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Angioplasty Criteria

A

-bloon must pass through blockage and can be removed by catheter
-blockage can NOT be in left main
-patient can’t be in heart failure
-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Angioplasty Advantages and risks

A
adv= less invasive, lower risk/cost/anesthesia, percuatious  incision, less recovery
risk/complications= bleeding, damage by catheter, restenosis, vessel closure, clots (treat with aspirin and clopidogrel), infections, MI, emergency CPB
-restenosis= 30-50% metal, 7-15% drug eluting
17
Q

Drug Eluting Stents

A

1) Boston= Taxus= chemotherapeutic drug
2) Johnson and Johnson/Cordis= Sirolimus= immunosuppressive
3) Medtronic= Zotarolium= immunosuppressive

18
Q

Atherectomy

A

= cutting out plaque (for calcified, fibrotic, hard plaque)

1) directional= cutting window- cuts and retrieves
2) Rotational= just spins/DIAMONDS- saline flush to cool= particles go down stream
3) Transluminal= cut and aspirate= lactated ringers and suction back
4) Laser
5) Transluminal Angiogenesis TMR= increase blood to areas that surgery/angioplasy can’t reach, uses CO2 laser
- go outside to inside and promotes new vessel growth

19
Q

Surgical Techniques

A

off bypass= MIDCAB, OPCAB (beating heart), assisted PADCAB

  • OPCAB= caution to life up heart, Medtronic Octopus 2, Ultima 2
  • DaVinci Robotic
20
Q

Percutaneous Mitral Valves

A

1) Abbot Mitraclip= first
2) Edwards Fortis= not is US
3) Neovasc= transapical insertion
4) Edwards Sapien XT= transapical (also for Aorta)

21
Q

Percutaneous Aortic Valves

A

1) Edwards Sapien 3/XT= cow tissue and added skirt (with 3)
2) Medtronic CoreValve and Evolut R (smaller)= approved for failed bioprosteic valve= “valve-in-valve”
- increases survival and lowers stroke
3) Sorin Perceval

22
Q

Percutaneous Valve Inserted at

A

transfemoral, transapical, subclavian , direct aortic